Lupin completes Phase 3 trials for Lucentis biosimilar Ruchika Sharma6 Aug 2024 4:30 PM ISTMumbai: Global Pharma major Lupin Limited has announced the successful completion of a global Phase 3 clinical study of LUBT010, its biosimilar...
Lupin collaborate with Amman Pharma for marketing, commercialization of Ranibizumab in Middle East region Ruchika Sharma11 Nov 2023 10:00 AM ISTMumbai: Global Pharma major Lupin Limited has partnered with Amman Pharmaceuticals Industries, a pharmaceutical manufacturer with operations across...
Lupin gets CDSCO panel nod to study Ranibizumab Dr. Divya Colin7 March 2023 6:00 PM ISTNew Delhi: The drug major Lupin has got the green signal from the Subject Expert Committee (SEC) from the Central Drug Standard Control Organisation...
Biogen, Samsung Bioepis launch USFDA approved BYOOVIZ in US Ruchika Sharma5 Jun 2022 9:00 AM ISTBYOOVIZ is the first biosimilar launch in the U.S. under the Biogen and Samsung Bioepis' partnership.
Intas Pharma, Axantia collaborate for Ranibizumab in Middle East Ruchika Sharma5 April 2022 12:20 PM ISTIntas has developed a biosimilar of Lucentis, which is currently under Phase III global trial for submission in major countries including EMA and the...
